InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,553.87
(
0.81%
)
US TECH 100
19,822.80
(
0.92%
)
Dow Jones
39,254.37
(
-0.14%
)
Brent Oil
87.25
(
-0.10%
)
Bitcoin
56,423.56
(
-0.98%
)
Post# of 21540
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

InTheTrenches

Send PM Follow Ignore
Followers 4
Posts 929
Boards Moderated 0
Alias Born 08/15/2006

InTheTrenches

Re: runncoach post# 6402

Friday, 07/06/2018 10:13:33 AM

Friday, July 06, 2018 10:13:33 AM

Post# of 21540
I agree. Doesn't seem to be any sign of reversing Alzheimer's.

About 850 total patients. So about 140 patients in each arm of the trial (5 different doses + placebo).

If I recall, Memantine showed stat. significance with fewer patients in each of their arms. This indicates to me that there is a smaller improvement in this Eisai/BIIB drug than Memantine. And Memantine doesn't really do much in terms of improving the lives of patients over the long-term.

But, it is a positive for the Amyloid theory.

For further discussion:

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=142012043



Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent SNPX News
More SNPX News
InvestorsHub NewsWire

Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM

Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM

EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM

BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM

NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM

Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM

Start posting your company's news
Only $200 per official company press release!